CD4 and cervical carcinoma: For example, a study retrospectively analyzed 40 biopsy samples from Chinese cervical cancer patients and found, when considering the deaths and surviving cases as separate groups, that the number of CD4+ T cells was significantly lower in patients who died compared with those who survived (26.33 ± 11.80 versus 47.79 ± 38.18, p = 0.023) (1).